InsiderSource
NUVL

Nuvalent, Inc.

SEC CIK 1861560
$123.45 +15.2% · 90 days
90-day buys
$0
0 open-market
90-day sells
$20.89M
52 open-market
Net insider flow
−$20.89M
Net selling
Filings shown
127
Most recent

At a glance

Over the last 90 days, insiders at NUVL have sold a net $20.89M of stock (0 open-market buys vs 52 sells).

Largest recent trade: Noci Darlene sold $2.46M of NUVL, trimming their stake 26%.

Most active filer: Noci Darlene, with 34 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for NUVL, newest first
View on SEC EDGAR ↗
NUVL
Nuvalent, Inc.
Option exercise Noci Darlene · Chief Development Officer · Option exercise · filed 1d ago ΔOwn +17%
+$10.8K
10,000 sh @ $1
NUVL
Nuvalent, Inc.
Option exercise Noci Darlene · Chief Development Officer · Option exercise · filed 1d ago ΔOwn +1.0%
+$4.7K
685 sh @ $7
NUVL
Nuvalent, Inc.
Option exercise Noci Darlene · Chief Development Officer · Option exercise · filed 1d ago ΔOwn +14%
+$176.3K
9,315 sh @ $19
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed 1d ago ΔOwn −26%

Noci Darlene sold $2.46M of NUVL, trimming their stake 26%.

−$2.46M
20,000 sh @ $123
NUVL
Nuvalent, Inc.
Sell Porter James Richard · Director, President and CEO · Open-market sale · filed 2d ago ΔOwn −3.5%

Porter James Richard sold $1.1M of NUVL, trimming their stake 4%.

−$1.1M
12,495 sh @ $88
NUVL
Nuvalent, Inc.
Sell Porter James Richard · Director, President and CEO · Open-market sale · filed 2d ago ΔOwn −4.2%

Porter James Richard sold $1.28M of NUVL, trimming their stake 4%.

−$1.28M
14,469 sh @ $89
NUVL
Nuvalent, Inc.
Sell Porter James Richard · Director, President and CEO · Open-market sale · filed 2d ago ΔOwn −0.9%

Porter James Richard sold $272.1K of NUVL, trimming their stake 1%.

−$272.1K
3,036 sh @ $90
NUVL
Nuvalent, Inc.
Option exercise Balcom Alexandra · Chief Financial Officer · Option exercise · filed 1w ago ΔOwn +13%
+$78.8K
11,430 sh @ $7
NUVL
Nuvalent, Inc.
Sell Balcom Alexandra · Chief Financial Officer · Open-market sale · filed 1w ago ΔOwn −1.0%

Balcom Alexandra sold $91.1K of NUVL, trimming their stake 1%.

−$91.1K
960 sh @ $95
NUVL
Nuvalent, Inc.
Sell Balcom Alexandra · Chief Financial Officer · Open-market sale · filed 1w ago ΔOwn −2.3%

Balcom Alexandra sold $208.3K of NUVL, trimming their stake 2%.

−$208.3K
2,170 sh @ $96
NUVL
Nuvalent, Inc.
Sell Balcom Alexandra · Chief Financial Officer · Open-market sale · filed 1w ago ΔOwn −1.0%

Balcom Alexandra sold $87.9K of NUVL, trimming their stake 1%.

−$87.9K
900 sh @ $98
NUVL
Nuvalent, Inc.
Sell Balcom Alexandra · Chief Financial Officer · Open-market sale · filed 1w ago ΔOwn −1.3%

Balcom Alexandra sold $118.3K of NUVL, trimming their stake 1%.

−$118.3K
1,200 sh @ $99
NUVL
Nuvalent, Inc.
Sell Balcom Alexandra · Chief Financial Officer · Open-market sale · filed 1w ago ΔOwn −3.4%

Balcom Alexandra sold $312.9K of NUVL, trimming their stake 3%.

−$312.9K
3,133 sh @ $100
NUVL
Nuvalent, Inc.
Sell Balcom Alexandra · Chief Financial Officer · Open-market sale · filed 1w ago ΔOwn −2.9%

Balcom Alexandra sold $260.5K of NUVL, trimming their stake 3%.

−$260.5K
2,588 sh @ $101
NUVL
Nuvalent, Inc.
Sell Balcom Alexandra · Chief Financial Officer · Open-market sale · filed 1w ago ΔOwn −0.3%

Balcom Alexandra sold $28.4K of NUVL.

−$28.4K
279 sh @ $102
NUVL
Nuvalent, Inc.
Sell Balcom Alexandra · Chief Financial Officer · Open-market sale · filed 1w ago ΔOwn −0.2%

Balcom Alexandra sold $20.8K of NUVL.

−$20.8K
200 sh @ $104
NUVL
Nuvalent, Inc.
Option exercise Noci Darlene · Chief Development Officer · Option exercise · filed 1w ago ΔOwn +9.5%
+$153.2K
5,500 sh @ $28
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed 1w ago ΔOwn −2.0%

Noci Darlene sold $138.1K of NUVL, trimming their stake 2%.

−$138.1K
1,300 sh @ $106
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed 1w ago ΔOwn −2.3%

Noci Darlene sold $152.6K of NUVL, trimming their stake 2%.

−$152.6K
1,422 sh @ $107
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed 1w ago ΔOwn −1.9%

Noci Darlene sold $127.2K of NUVL, trimming their stake 2%.

−$127.2K
1,178 sh @ $108
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed 1w ago ΔOwn −2.5%

Noci Darlene sold $164K of NUVL, trimming their stake 3%.

−$164K
1,500 sh @ $109
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed 1w ago ΔOwn −0.2%

Noci Darlene sold $11K of NUVL.

−$11K
100 sh @ $110
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed 1w ago ΔOwn −2.2%

Miller Deborah Ann sold $149K of NUVL, trimming their stake 2%.

−$149K
1,401 sh @ $106
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed 1w ago ΔOwn −2.4%

Miller Deborah Ann sold $164.4K of NUVL, trimming their stake 2%.

−$164.4K
1,530 sh @ $107
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed 1w ago ΔOwn −1.4%

Miller Deborah Ann sold $97.3K of NUVL, trimming their stake 1%.

−$97.3K
900 sh @ $108
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed 1w ago ΔOwn −2.7%

Miller Deborah Ann sold $182.4K of NUVL, trimming their stake 3%.

−$182.4K
1,669 sh @ $109
NUVL
Nuvalent, Inc.
Sell Porter James Richard · Director, President and CEO · Open-market sale · filed May 6, 2026 ΔOwn −0.5%

Porter James Richard sold $167.4K of NUVL.

−$167.4K
1,699 sh @ $99
NUVL
Nuvalent, Inc.
Sell Porter James Richard · Director, President and CEO · Open-market sale · filed May 6, 2026 ΔOwn −0.4%

Porter James Richard sold $140.5K of NUVL.

−$140.5K
1,408 sh @ $100
NUVL
Nuvalent, Inc.
Sell Porter James Richard · Director, President and CEO · Open-market sale · filed May 6, 2026 ΔOwn −2.1%

Porter James Richard sold $753.9K of NUVL, trimming their stake 2%.

−$753.9K
7,429 sh @ $101
NUVL
Nuvalent, Inc.
Sell Porter James Richard · Director, President and CEO · Open-market sale · filed May 6, 2026 ΔOwn −5.0%

Porter James Richard sold $1.77M of NUVL, trimming their stake 5%.

−$1.77M
17,353 sh @ $102
NUVL
Nuvalent, Inc.
Sell Porter James Richard · Director, President and CEO · Open-market sale · filed May 6, 2026 ΔOwn −0.6%

Porter James Richard sold $217.2K of NUVL, trimming their stake 1%.

−$217.2K
2,111 sh @ $103
NUVL
Nuvalent, Inc.
Option exercise Balcom Alexandra · Chief Financial Officer · Option exercise · filed May 5, 2026 ΔOwn +8.4%
+$7.7K
7,159 sh @ $1
NUVL
Nuvalent, Inc.
Option exercise Balcom Alexandra · Chief Financial Officer · Option exercise · filed May 5, 2026 ΔOwn +4.6%
+$29.4K
4,271 sh @ $7
NUVL
Nuvalent, Inc.
Sell Balcom Alexandra · Chief Financial Officer · Open-market sale · filed May 5, 2026 ΔOwn −4.0%

Balcom Alexandra sold $381.1K of NUVL, trimming their stake 4%.

−$381.1K
3,872 sh @ $98
NUVL
Nuvalent, Inc.
Sell Balcom Alexandra · Chief Financial Officer · Open-market sale · filed May 5, 2026 ΔOwn −8.0%

Balcom Alexandra sold $738.1K of NUVL, trimming their stake 8%.

−$738.1K
7,434 sh @ $99
NUVL
Nuvalent, Inc.
Sell Balcom Alexandra · Chief Financial Officer · Open-market sale · filed May 5, 2026 ΔOwn −0.1%

Balcom Alexandra sold $12.4K of NUVL.

−$12.4K
124 sh @ $100
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed May 1, 2026 ΔOwn −6.8%

Miller Deborah Ann sold $438K of NUVL, trimming their stake 7%.

−$438K
4,418 sh @ $99
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed May 1, 2026 ΔOwn −1.8%

Miller Deborah Ann sold $107.7K of NUVL, trimming their stake 2%.

−$107.7K
1,082 sh @ $100
NUVL
Nuvalent, Inc.
Option exercise Noci Darlene · Chief Development Officer · Option exercise · filed May 1, 2026 ΔOwn +9.5%
+$153.2K
5,500 sh @ $28
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed May 1, 2026 ΔOwn −7.1%

Noci Darlene sold $447.1K of NUVL, trimming their stake 7%.

−$447.1K
4,500 sh @ $99
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed May 1, 2026 ΔOwn −1.2%

Noci Darlene sold $70.1K of NUVL, trimming their stake 1%.

−$70.1K
700 sh @ $100
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed May 1, 2026 ΔOwn −0.5%

Noci Darlene sold $30.4K of NUVL, trimming their stake 1%.

−$30.4K
300 sh @ $101
NUVL
Nuvalent, Inc.
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Apr 13, 2026 ΔOwn +4.7%
+$86.1K
3,093 sh @ $28
NUVL
Nuvalent, Inc.
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Apr 13, 2026 ΔOwn −3.2%

Pelish Henry E. sold $228.7K of NUVL, trimming their stake 3%.

−$228.7K
2,193 sh @ $104
NUVL
Nuvalent, Inc.
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Apr 13, 2026 ΔOwn −1.4%

Pelish Henry E. sold $94.5K of NUVL, trimming their stake 1%.

−$94.5K
900 sh @ $105
NUVL
Nuvalent, Inc.
Sell Porter James Richard · Director, President and CEO · Open-market sale · filed Apr 8, 2026 ΔOwn −3.2%

Porter James Richard sold $1.17M of NUVL, trimming their stake 3%.

−$1.17M
11,354 sh @ $103
NUVL
Nuvalent, Inc.
Sell Porter James Richard · Director, President and CEO · Open-market sale · filed Apr 8, 2026 ΔOwn −3.6%

Porter James Richard sold $1.29M of NUVL, trimming their stake 4%.

−$1.29M
12,425 sh @ $104
NUVL
Nuvalent, Inc.
Sell Porter James Richard · Director, President and CEO · Open-market sale · filed Apr 8, 2026 ΔOwn −1.8%

Porter James Richard sold $641.4K of NUVL, trimming their stake 2%.

−$641.4K
6,121 sh @ $105
NUVL
Nuvalent, Inc.
Sell Porter James Richard · Director, President and CEO · Open-market sale · filed Apr 8, 2026

Porter James Richard sold $10.6K of NUVL.

−$10.6K
100 sh @ $106
NUVL
Nuvalent, Inc.
Option exercise Balcom Alexandra · Chief Financial Officer · Option exercise · filed Apr 3, 2026 ΔOwn +13%
+$12.3K
11,430 sh @ $1
NUVL
Nuvalent, Inc.
Sell Balcom Alexandra · Chief Financial Officer · Open-market sale · filed Apr 3, 2026 ΔOwn −3.7%

Balcom Alexandra sold $370K of NUVL, trimming their stake 4%.

−$370K
3,544 sh @ $104
NUVL
Nuvalent, Inc.
Sell Balcom Alexandra · Chief Financial Officer · Open-market sale · filed Apr 3, 2026 ΔOwn −5.8%

Balcom Alexandra sold $570.4K of NUVL, trimming their stake 6%.

−$570.4K
5,417 sh @ $105
NUVL
Nuvalent, Inc.
Sell Balcom Alexandra · Chief Financial Officer · Open-market sale · filed Apr 3, 2026 ΔOwn −2.8%

Balcom Alexandra sold $262.2K of NUVL, trimming their stake 3%.

−$262.2K
2,469 sh @ $106
NUVL
Nuvalent, Inc.
Option exercise Noci Darlene · Chief Development Officer · Option exercise · filed Apr 1, 2026 ΔOwn +9.5%
+$153.2K
5,500 sh @ $28
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed Apr 1, 2026 ΔOwn −4.0%

Noci Darlene sold $246.7K of NUVL, trimming their stake 4%.

−$246.7K
2,532 sh @ $97
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed Apr 1, 2026 ΔOwn −4.9%

Noci Darlene sold $291.2K of NUVL, trimming their stake 5%.

−$291.2K
2,968 sh @ $98
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed Mar 30, 2026 ΔOwn −1.4%

Miller Deborah Ann sold $91.7K of NUVL, trimming their stake 1%.

−$91.7K
940 sh @ $98
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed Mar 30, 2026 ΔOwn −2.7%

Miller Deborah Ann sold $172.6K of NUVL, trimming their stake 3%.

−$172.6K
1,757 sh @ $98
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed Mar 30, 2026 ΔOwn −4.5%

Miller Deborah Ann sold $278.8K of NUVL, trimming their stake 4%.

−$278.8K
2,803 sh @ $99
NUVL
Nuvalent, Inc.
Sell Balcom Alexandra · Chief Financial Officer · Open-market sale · filed Mar 26, 2026 ΔOwn −14%

Balcom Alexandra sold $1.37M of NUVL, trimming their stake 14%.

−$1.37M
13,700 sh @ $100
NUVL
Nuvalent, Inc.
Option exercise Balcom Alexandra · Chief Financial Officer · Option exercise · filed Mar 26, 2026 ΔOwn +12%
+$12.3K
11,430 sh @ $1
NUVL
Nuvalent, Inc.
Sell Balcom Alexandra · Chief Financial Officer · Open-market sale · filed Mar 26, 2026 ΔOwn −2.3%

Balcom Alexandra sold $247K of NUVL, trimming their stake 2%.

−$247K
2,599 sh @ $95
NUVL
Nuvalent, Inc.
Sell Balcom Alexandra · Chief Financial Officer · Open-market sale · filed Mar 26, 2026 ΔOwn −7.1%

Balcom Alexandra sold $735.5K of NUVL, trimming their stake 7%.

−$735.5K
7,671 sh @ $96
NUVL
Nuvalent, Inc.
Sell Balcom Alexandra · Chief Financial Officer · Open-market sale · filed Mar 26, 2026 ΔOwn −1.2%

Balcom Alexandra sold $111.9K of NUVL, trimming their stake 1%.

−$111.9K
1,160 sh @ $97
NUVL
Nuvalent, Inc.
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Mar 16, 2026 ΔOwn −1.1%

Pelish Henry E. sold $78.7K of NUVL, trimming their stake 1%.

−$78.7K
804 sh @ $98
NUVL
Nuvalent, Inc.
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Mar 16, 2026 ΔOwn −3.7%

Pelish Henry E. sold $256.7K of NUVL, trimming their stake 4%.

−$256.7K
2,597 sh @ $99
NUVL
Nuvalent, Inc.
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Mar 16, 2026 ΔOwn −2.5%

Pelish Henry E. sold $169.8K of NUVL, trimming their stake 3%.

−$169.8K
1,703 sh @ $100
NUVL
Nuvalent, Inc.
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Mar 16, 2026 ΔOwn +10%
+$160.1K
8,456 sh @ $19
NUVL
Nuvalent, Inc.
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Mar 16, 2026 ΔOwn +1.9%
+$48.8K
1,754 sh @ $28
NUVL
Nuvalent, Inc.
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Mar 16, 2026 ΔOwn +4.4%
+$121K
4,125 sh @ $29
NUVL
Nuvalent, Inc.
Option exercise Pelish Henry E. · Chief Scientific Officer · Option exercise · filed Mar 16, 2026 ΔOwn +3.1%
+$216K
2,985 sh @ $72
NUVL
Nuvalent, Inc.
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Mar 16, 2026 ΔOwn −24%

Pelish Henry E. sold $2.37M of NUVL, trimming their stake 24%.

−$2.37M
24,189 sh @ $98
NUVL
Nuvalent, Inc.
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Mar 16, 2026 ΔOwn −7.2%

Pelish Henry E. sold $541.9K of NUVL, trimming their stake 7%.

−$541.9K
5,505 sh @ $98
NUVL
Nuvalent, Inc.
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Mar 16, 2026 ΔOwn −0.4%

Pelish Henry E. sold $30.3K of NUVL.

−$30.3K
306 sh @ $99
NUVL
Nuvalent, Inc.
Sell Porter James Richard · Director, President and CEO · Open-market sale · filed Mar 10, 2026 ΔOwn −3.8%

Porter James Richard sold $1.34M of NUVL, trimming their stake 4%.

−$1.34M
13,585 sh @ $99
NUVL
Nuvalent, Inc.
Sell Porter James Richard · Director, President and CEO · Open-market sale · filed Mar 10, 2026 ΔOwn −4.7%

Porter James Richard sold $1.59M of NUVL, trimming their stake 5%.

−$1.59M
16,015 sh @ $99
NUVL
Nuvalent, Inc.
Sell Porter James Richard · Director, President and CEO · Open-market sale · filed Mar 10, 2026 ΔOwn −0.1%

Porter James Richard sold $40.1K of NUVL.

−$40.1K
400 sh @ $100
NUVL
Nuvalent, Inc.
Option exercise Noci Darlene · Chief Development Officer · Option exercise · filed Mar 2, 2026 ΔOwn +9.5%
+$153.2K
5,500 sh @ $28
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed Mar 2, 2026 ΔOwn −4.7%

Noci Darlene sold $307.9K of NUVL, trimming their stake 5%.

−$307.9K
3,000 sh @ $103
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed Mar 2, 2026 ΔOwn −3.8%

Noci Darlene sold $237.9K of NUVL, trimming their stake 4%.

−$237.9K
2,300 sh @ $103
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed Mar 2, 2026 ΔOwn −0.3%

Noci Darlene sold $20.9K of NUVL.

−$20.9K
200 sh @ $104
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed Mar 2, 2026 ΔOwn −4.1%

Miller Deborah Ann sold $276.9K of NUVL, trimming their stake 4%.

−$276.9K
2,698 sh @ $103
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed Mar 2, 2026 ΔOwn −4.2%

Miller Deborah Ann sold $269.1K of NUVL, trimming their stake 4%.

−$269.1K
2,602 sh @ $103
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed Mar 2, 2026 ΔOwn −0.3%

Miller Deborah Ann sold $20.8K of NUVL.

−$20.8K
200 sh @ $104
NUVL
Nuvalent, Inc.
Option exercise Noci Darlene · Chief Development Officer · Option exercise · filed Feb 2, 2026 ΔOwn +9.5%
+$153.2K
5,500 sh @ $28
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed Feb 2, 2026 ΔOwn −0.3%

Noci Darlene sold $19.1K of NUVL.

−$19.1K
189 sh @ $101
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed Feb 2, 2026 ΔOwn −5.4%

Noci Darlene sold $349.1K of NUVL, trimming their stake 5%.

−$349.1K
3,429 sh @ $102
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed Feb 2, 2026 ΔOwn −3.0%

Noci Darlene sold $186.8K of NUVL, trimming their stake 3%.

−$186.8K
1,819 sh @ $103
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed Feb 2, 2026 ΔOwn −0.1%

Noci Darlene sold $6.5K of NUVL.

−$6.5K
63 sh @ $103
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed Jan 23, 2026 ΔOwn −19%

Miller Deborah Ann sold $1.58M of NUVL, trimming their stake 19%.

−$1.58M
14,300 sh @ $110
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed Jan 23, 2026 ΔOwn −1.2%

Miller Deborah Ann sold $76.9K of NUVL, trimming their stake 1%.

−$76.9K
700 sh @ $110
NUVL
Nuvalent, Inc.
Grant/award Noci Darlene · Chief Development Officer · Grant/award · filed Jan 7, 2026 ΔOwn +43%
+$0
17,500 sh
NUVL
Nuvalent, Inc.
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −1.6%

Pelish Henry E. sold $107K of NUVL, trimming their stake 2%.

−$107K
1,106 sh @ $97
NUVL
Nuvalent, Inc.
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −2.0%

Pelish Henry E. sold $133.2K of NUVL, trimming their stake 2%.

−$133.2K
1,369 sh @ $97
NUVL
Nuvalent, Inc.
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −0.3%

Pelish Henry E. sold $18.6K of NUVL.

−$18.6K
189 sh @ $98
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −3.0%

Noci Darlene sold $127.8K of NUVL, trimming their stake 3%.

−$127.8K
1,321 sh @ $97
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −3.8%

Noci Darlene sold $159.1K of NUVL, trimming their stake 4%.

−$159.1K
1,635 sh @ $97
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −0.6%

Noci Darlene sold $22.1K of NUVL, trimming their stake 1%.

−$22.1K
225 sh @ $98
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −2.4%

Miller Deborah Ann sold $104K of NUVL, trimming their stake 2%.

−$104K
1,075 sh @ $97
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −3.0%

Miller Deborah Ann sold $129.5K of NUVL, trimming their stake 3%.

−$129.5K
1,331 sh @ $97
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −0.4%

Miller Deborah Ann sold $18K of NUVL.

−$18K
183 sh @ $98
NUVL
Nuvalent, Inc.
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −0.7%

Pelish Henry E. sold $49.3K of NUVL, trimming their stake 1%.

−$49.3K
513 sh @ $96
NUVL
Nuvalent, Inc.
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −0.9%

Pelish Henry E. sold $63.9K of NUVL, trimming their stake 1%.

−$63.9K
660 sh @ $97
NUVL
Nuvalent, Inc.
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −1.6%

Pelish Henry E. sold $111.4K of NUVL, trimming their stake 2%.

−$111.4K
1,137 sh @ $98
NUVL
Nuvalent, Inc.
Sell Pelish Henry E. · Chief Scientific Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −0.3%

Pelish Henry E. sold $18.3K of NUVL.

−$18.3K
186 sh @ $99
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −1.8%

Noci Darlene sold $83.7K of NUVL, trimming their stake 2%.

−$83.7K
871 sh @ $96
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −2.4%

Noci Darlene sold $108.4K of NUVL, trimming their stake 2%.

−$108.4K
1,119 sh @ $97
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −4.2%

Noci Darlene sold $189K of NUVL, trimming their stake 4%.

−$189K
1,929 sh @ $98
NUVL
Nuvalent, Inc.
Sell Noci Darlene · Chief Development Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −0.7%

Noci Darlene sold $31.2K of NUVL, trimming their stake 1%.

−$31.2K
317 sh @ $99
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −1.8%

Miller Deborah Ann sold $86.2K of NUVL, trimming their stake 2%.

−$86.2K
897 sh @ $96
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −2.4%

Miller Deborah Ann sold $111.7K of NUVL, trimming their stake 2%.

−$111.7K
1,153 sh @ $97
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −4.2%

Miller Deborah Ann sold $194.6K of NUVL, trimming their stake 4%.

−$194.6K
1,987 sh @ $98
NUVL
Nuvalent, Inc.
Sell Miller Deborah Ann · Chief Legal Officer · Open-market sale · filed Jan 7, 2026 ΔOwn −0.7%

Miller Deborah Ann sold $32.1K of NUVL, trimming their stake 1%.

−$32.1K
326 sh @ $99

About NUVL insider activity

This page tracks every recent Form 4 filed for Nuvalent, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is NUVL insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Nuvalent, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.